| 000 | 01798 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514055940.0 | ||
| 264 | 0 | _c20030604 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdg070 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLimat, S | |
| 245 | 0 | 0 |
_aEarly cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cFeb 2003 |
||
| 300 |
_a277-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xchemically induced |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aDemesmay, K | |
| 700 | 1 | _aVoillat, L | |
| 700 | 1 | _aBernard, Y | |
| 700 | 1 | _aDeconinck, E | |
| 700 | 1 | _aBrion, A | |
| 700 | 1 | _aSabbah, A | |
| 700 | 1 | _aWoronoff-Lemsi, M C | |
| 700 | 1 | _aCahn, J Y | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 14 _gno. 2 _gp. 277-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdg070 _zAvailable from publisher's website |
| 999 |
_c12361565 _d12361565 |
||